Detailed price information for Unitedhealth Group Inc (UNH-N) from The Globe and Mail including charting and trades.

CVS Health’s first quarter results reflected steady execution across its core businesses, with management highlighting ...

Novo Nordisk has terminated its partnership with telehealth company Hims & Hers Health, accusing it of deceptively marketing weight-loss drugs.

The new Centers for Medicare and Medicaid Services head did not talk about new defenses against unnecessary spending.

Curay, the acting director of the FDA’s Center for Drug Evaluation and Research, internally announced her retirement Monday.

Strong efficacy and cardiovascular benefits should allow Novo to continue growing sales of GLP-1 therapies in diabetes. While Novo lost share to Eli Lilly's once-weekly Trulicity, Ozempic and Rybelsus ...

The FDA had resolved the shortage of Wegovy in April, and telehealth providers were advised to stop selling compounded ...

CVS' Health Services segment posts $43B in revenues as specialty pharmacy and Caremark deals drive 2025 growth prospects.

Medicare no longer covers Wegovy specifically for weight loss purposes, though coverage may still be available when prescribed for other medical conditions. Exception requests from doctors may provide ...

The federal Medicare insurance program does not cover the medications for obesity but does cover Zepbound for sleep apnea and Wegovy for reducing cardiovascular risk. Many patients who lack insurance ...